PortfoliosLab logoPortfoliosLab logo
JNJ vs. MA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

JNJ vs. MA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Johnson & Johnson (JNJ) and Mastercard Incorporated (MA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, JNJ achieves a 13.72% return, which is significantly higher than MA's -13.70% return. Over the past 10 years, JNJ has underperformed MA with an annualized return of 10.21%, while MA has yielded a comparatively higher 18.35% annualized return.


JNJ

1D
2.02%
1M
4.22%
YTD
13.72%
6M
16.55%
1Y
55.27%
3Y*
17.11%
5Y*
10.05%
10Y*
10.21%

MA

1D
1.93%
1M
-0.16%
YTD
-13.70%
6M
-9.69%
1Y
-15.62%
3Y*
9.57%
5Y*
6.67%
10Y*
18.35%
*Multi-year figures are annualized to reflect compound growth (CAGR)

JNJ vs. MA - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
JNJ
Johnson & Johnson
13.72%47.48%-4.81%-8.58%5.97%11.44%10.82%16.22%-5.13%24.43%
MA
Mastercard Incorporated
-13.70%9.04%24.17%23.40%-2.66%1.16%20.19%59.16%25.31%47.69%

Correlation

The correlation between JNJ and MA is 0.10, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.10

Correlation (3Y)
Calculated over the trailing 3-year period

0.18

Correlation (5Y)
Calculated over the trailing 5-year period

0.23

Correlation (10Y)
Calculated over the trailing 10-year period

0.29

Correlation (All Time)
Calculated using the full available price history since May 26, 2006

0.34

Over the past year, the correlation between JNJ and MA has dropped to 0.10 - well below their long-term average of 0.34, suggesting their price drivers have been diverging.

Fundamentals

Market Cap

JNJ:

$569.17B

MA:

$438.53B

EPS

JNJ:

$8.65

MA:

$17.28

PE Ratio

JNJ:

26.92

MA:

28.43

PEG Ratio

JNJ:

0.90

MA:

1.66

PS Ratio

JNJ:

5.88

MA:

13.04

PB Ratio

JNJ:

7.01

MA:

65.24

Total Revenue (TTM)

JNJ:

$96.36B

MA:

$33.94B

Gross Profit (TTM)

JNJ:

$66.60B

MA:

$26.70B

EBITDA (TTM)

JNJ:

$31.62B

MA:

$21.23B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

JNJ vs. MA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JNJ
JNJ Risk / Return Rank: 9494
Overall Rank
JNJ Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
JNJ Sortino Ratio Rank: 9797
Sortino Ratio Rank
JNJ Omega Ratio Rank: 9595
Omega Ratio Rank
JNJ Calmar Ratio Rank: 9191
Calmar Ratio Rank
JNJ Martin Ratio Rank: 9393
Martin Ratio Rank

MA
MA Risk / Return Rank: 1212
Overall Rank
MA Sharpe Ratio Rank: 1212
Sharpe Ratio Rank
MA Sortino Ratio Rank: 1414
Sortino Ratio Rank
MA Omega Ratio Rank: 1414
Omega Ratio Rank
MA Calmar Ratio Rank: 1313
Calmar Ratio Rank
MA Martin Ratio Rank: 55
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JNJ vs. MA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Johnson & Johnson (JNJ) and Mastercard Incorporated (MA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


JNJMADifference
Sharpe ratioReturn per unit of total volatility

+4.00

Sortino ratioReturn per unit of downside risk

+5.63

Omega ratioGain probability vs. loss probability

1.59

0.89

+0.69

Calmar ratioReturn relative to maximum drawdown

5.07

-0.75

+5.82

Martin ratioReturn relative to average drawdown

15.08

-1.54

+16.61

JNJ vs. MA - Sharpe Ratio Comparison

The current JNJ Sharpe Ratio is 3.30, which is higher than the MA Sharpe Ratio of -0.71. The chart below compares the historical Sharpe Ratios of JNJ and MA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


JNJMADifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

3.30

-0.71

+4.00

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.60

0.28

+0.32

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.55

0.68

-0.13

Sharpe Ratio (All Time)

Calculated using the full available price history

0.54

0.83

-0.30

Drawdowns

JNJ vs. MA - Drawdown Comparison

The maximum JNJ drawdown since its inception was -50.67%, smaller than the maximum MA drawdown of -62.67%. Use the drawdown chart below to compare losses from any high point for JNJ and MA.


Loading charts...

Drawdown Indicators


JNJMADifference

Max Drawdown

Largest peak-to-trough decline

-50.67%

-62.67%

+12.00%

Max Drawdown (1Y)

Largest decline over 1 year

-10.96%

-20.91%

+9.95%

Max Drawdown (3Y)

Largest decline over 3 years

-15.95%

-20.91%

+4.96%

Max Drawdown (5Y)

Largest decline over 5 years

-18.41%

-28.25%

+9.84%

Max Drawdown (10Y)

Largest decline over 10 years

-27.37%

-41.00%

+13.63%

Current Drawdown

Current decline from peak

-5.81%

-17.64%

+11.83%

Average Drawdown

Average peak-to-trough decline

-11.88%

-9.82%

-2.06%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.68%

10.19%

-6.51%

Volatility

JNJ vs. MA - Volatility Comparison

The current volatility for Johnson & Johnson (JNJ) is 5.90%, while Mastercard Incorporated (MA) has a volatility of 6.54%. This indicates that JNJ experiences smaller price fluctuations and is considered to be less risky than MA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


JNJMADifference

Volatility (1M)

Calculated over the trailing 1-month period

5.90%

6.54%

-0.64%

Volatility (6M)

Calculated over the trailing 6-month period

12.49%

17.46%

-4.97%

Volatility (1Y)

Calculated over the trailing 1-year period

16.85%

22.23%

-5.38%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

16.87%

23.98%

-7.11%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.46%

26.92%

-8.46%

Dividends

JNJ vs. MA - Dividend Comparison

JNJ's dividend yield for the trailing twelve months is around 2.25%, more than MA's 0.66% yield.


PositionTTM20252024202320222021202020192018201720162015
JNJ
Johnson & Johnson
2.25%2.48%3.40%3.00%2.52%2.45%2.53%2.57%2.74%2.38%2.73%2.87%
MA
Mastercard Incorporated
0.66%0.53%0.50%0.53%0.56%0.49%0.45%0.44%0.53%0.58%0.74%0.66%

Financials

JNJ vs. MA - Financials Comparison

This section allows you to compare key financial metrics between Johnson & Johnson and Mastercard Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


5.00B10.00B15.00B20.00B25.00B20222023202420252026
24.06B
8.40B
(JNJ) Total Revenue
(MA) Total Revenue
Values in USD except per share items

JNJ vs. MA - Profitability Comparison

The chart below illustrates the profitability comparison between Johnson & Johnson and Mastercard Incorporated over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%70.0%80.0%90.0%100.0%20222023202420252026
71.5%
58.4%
Portfolio components
JNJ - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a gross profit of 17.20B and revenue of 24.06B. Therefore, the gross margin over that period was 71.5%.

MA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Mastercard Incorporated reported a gross profit of 4.91B and revenue of 8.40B. Therefore, the gross margin over that period was 58.4%.

JNJ - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported an operating income of 6.40B and revenue of 24.06B, resulting in an operating margin of 26.6%.

MA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Mastercard Incorporated reported an operating income of 4.91B and revenue of 8.40B, resulting in an operating margin of 58.4%.

JNJ - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a net income of 5.24B and revenue of 24.06B, resulting in a net margin of 21.8%.

MA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Mastercard Incorporated reported a net income of 3.88B and revenue of 8.40B, resulting in a net margin of 46.2%.


Frequently Asked Questions


JNJ and MA have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MA has higher volatility (6.54%) compared to JNJ (5.90%). In terms of maximum drawdown, JNJ dropped -50.67% vs MA's -62.67%.

JNJ currently has the higher Sharpe Ratio (3.30 vs -0.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for JNJ and MA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer